CCL16/LEC powerfully triggers effector and antigen-presenting functions of macrophages and enhances T cell cytotoxicity
Rats, Inbred LEC
Cell Survival
Tumor Necrosis Factor-alpha
T-Lymphocytes
Immunology
Antigen-Presenting Cells
Cell Biology
Macrophage Activation
Interleukin-12
Recombinant Proteins
CCL16; macrophages; antigen presentations; CTL; T cell activation
Rats
3. Good health
Mice
03 medical and health sciences
0302 clinical medicine
Chemokines, CC
Macrophages, Peritoneal
Immunology and Allergy
Animals
Humans
Interleukin-1
T-Lymphocytes, Cytotoxic
DOI:
10.1189/jlb.0403146
Publication Date:
2003-10-07T00:16:07Z
AUTHORS (7)
ABSTRACT
AbstractThe huan CC chemokine CCL16, a liver-expressed chemokine, enhances the killing activity of mouse peritoneal macrophages by triggering their expression of tumor necrosis factor α (TNF-α) and Fas ligand. Macrophages also respond to CCL16 by enhancing their production of monocyte chemoattractant protein-1, regulated on activation, normal T cells expressed and secreted chemokines, and interleukin (IL)-1β, TNF-α, and IL-12. The effect of CCL16 is almost as strong as that of lipopolysaccharide and interferon-γ, two of the best macrophage activators. Moreover, CCL16-activated macrophages overexpress membrane CD80, CD86, and CD40 costimulatory molecules and extensively phagocytose tumor cell debris. On exposure to such debris, they activate a strong, tumor-specific, cytolytic response in virgin T cells. Furthermore, cytolytic T cells generated in the presence of CCL16 display a higher cytotoxicity and activate caspase-8 in tumor target cells. This ability to activate caspase-8 depends on their overexpression of TNF-α and Fas ligand induced by CCL16. These data reveal a new function for CCL16 in the immune-response scenario. CCL16 significantly enhances the effector and the antigen-presenting function of macrophages and augments T cell lytic activity.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (45)
CITATIONS (34)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....